COSMO PHARMACEUT. EO-,26/ NL0011832936 /
9/2/2024 11:30:01 AM | Chg. -0.5000 | Volume | Bid11:43:38 AM | Ask12:01:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
83.0000EUR | -0.60% | 0 Turnover: 0.0000 |
83.0000Bid Size: 40 | 87.0000Ask Size: 30 | 1.37 bill.EUR | 2.37% | 1,190.66 |
Assets
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 21.7000 | 21.4000 | 21.1000 | 20.7000 | 30.2000 | ||||||
Intangible Assets | 16.3000 | 10.3000 | 4.5000 | 19.5000 | 28.5000 | ||||||
Long-Term Investments | 15.5000 | 120.8000 | 127.1000 | 72 | 93.8000 | ||||||
Fixed Assets | 54.7000 | 154.9000 | 300 | 256.4000 | 300.7000 | ||||||
Inventories | 2.9000 | 3.3000 | 2.2000 | 2.3000 | 3.2000 | ||||||
Accounts Receivable | 11.6000 | 4.8000 | 16.8000 | 15 | 13.2000 | ||||||
Cash and Cash Equivalents | 46.3000 | 34.1000 | 71.3000 | 117.6000 | 144.9000 | ||||||
Current Assets | 188.3000 | 70.7000 | 137.9000 | 187.1000 | 197.3000 | ||||||
Total Assets | 243 | 225.6000 | 437.9000 | 443.5000 | 498 |
Liabilities
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 4.2000 | 5.5000 | 4.3000 | 6.1000 | 11.3000 | ||||||
Long-term debt | 9.8000 | 8.9000 | 6.6000 | 4.5000 | 3.8000 | ||||||
Liabilities to Banks | 11.8000 | 10.9000 | 8.2000 | 5.3000 | 4.4000 | ||||||
Provisions | 3 | 3.3000 | 2.3000 | 4.3000 | 4.3000 | ||||||
Liabilities | 22.8000 | 73.3000 | 34.3000 | 27.9000 | 27.9000 | ||||||
Share Capital | 3.7000 | 3.7000 | 3.7000 | 3.7000 | 3.9000 | ||||||
Total Equity | 220.1000 | 152.3000 | 403.6000 | 415.5000 | 470.1000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 243 | 225.6000 | 437.9000 | 443.5000 | 498 |
Income Statement
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 56.4000 | 79.6000 | 60.6000 | 67.7000 | 67.2000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 12.9000 | 22.2000 | -7.5000 | 21 | -15.5000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 71.7000 | 108.9000 | -261.3000 | 27.5000 | -32.4000 | ||||||
Income Taxes | -3 | -35.6000 | -6.1000 | -8.2000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | 68.7000 | 73.3000 | 248.2000 | 19.3000 | -32.4000 |
Per Share
Cash Flow
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 8.1000 | 66.4000 | -39.2000 | 26.4000 | -10 | ||||||
Cash Flow from Investing Activities | -3.2000 | -11.5000 | 78.9000 | 40.2000 | -22.3000 | ||||||
Cash Flow from Financing | 14.1000 | -67.1000 | -2.6000 | -22.6000 | 72.7000 | ||||||
Decrease / Increase in Cash | 19 | -12.2000 | 37.1000 | 46.4000 | 40.4000 | ||||||
Employees | 163 | 178 | 183 | 217 | 301 |